John D. McDermott is CEO at ENDOLOGIX INC /DE/ (ELGX). They have made 9 open-market trades across 1 company since 2008, most recently 2018-05-29.
CIK 0001435020
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $707K since 2008, against 2 sales. Across 7 scored buys the stock is down 4.5% at ninety days, and 5.2 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ELGX | 886,709 | $195K |
Shares reported on the most recent Form 4, priced at the 2018-05-30 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 86% | 57% |
| Avg Move | -7.5% | +1.0% | -4.5% |
| Alpha | -3.4% | +0.8% | -5.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELGX | BUY | 2017-05-19 | 2017-05-30 | $4.45 | $111K | +5.0% | +7.3% | -6.7% |
| ELGX | BUY | 2016-12-14 | 2016-12-15 | $6.67 | $67K | -23.1% | -8.4% | -6.5% |
| ELGX | SELL | 2016-06-01 | 2016-06-02 | $12.55 | $154K | -2.2% | -1.3% | -6.5% |
| ELGX | BUY | 2015-11-02 | 2015-11-03 | $8.90 | $178K | -6.9% | +1.5% | -24.8% |
| ELGX | BUY | 2014-11-04 | 2014-11-05 | $11.25 | $281K | -6.9% | +1.5% | +1.5% |
| ELGX | SELL · 10b5-1 | 2013-08-05 | 2013-08-06 | $16.00 | $2.6M | -6.9% | +1.5% | +1.5% |
| ELGX | SELL · 10b5-1 | 2013-08-01 | 2013-08-02 | $15.83 | $220K | -6.9% | +1.5% | +1.5% |
| ELGX | SELL | 2010-05-14 | 2010-05-17 | $5.01 | $1.1M | -6.9% | +1.5% | +1.5% |
| ELGX | BUY | 2009-05-05 | 2009-05-06 | $2.20 | $22K | -6.9% | +1.5% | +1.5% |
| ELGX | BUY | 2009-05-01 | 2009-05-05 | $2.25 | $23K | -6.9% | +1.5% | +1.5% |
| ELGX | BUY | 2008-06-06 | 2008-06-09 | $2.49 | $25K | -6.9% | +1.5% | +1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.